Nascent-stage fund (~$10M cap) from a 25,000+ member women's leadership movement, enabling many first-time women and women-of-color LPs and leveraging LPs for sourcing and subject-matter expertise. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startup ventures with exceptional defensibility and operational guidance from GP Rob Ness’s 2% Rule. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Co-founder-focused fund for lab-based teams at the health–climate intersection (gene therapy, synthetic biology, batteries), providing deep access to UC Berkeley, UCSF, MIT and Stanford research and scientist-founders. The firm continues to build its presence across the venture capital landscape.
Operator-led biotech fund run by ex-founders targeting young PhD/postdoc and emerging academic scientists, focusing on overlooked genomics, diagnostics and AI-in-biotech, delivering a Fellowship and academic partnerships With a disciplined investment approach, the team drives value for both founders and investors.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
Nascent-stage, first-money-in partner for technically ambitious founders transforming the physical world (energy, defense, infrastructure, space, advanced manufacturing). Standing apart by underwriting elevated technical and regulatory risk.
Is dedicated to companies empowering informed, connected health consumers and building system-level resilience to improve outcomes, experiences, and lower healthcare costs. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
